Impact of qnrA1, qnrB1 and qnrS1 on the efficacy of ciprofloxacin and levofloxacin in an experimental pneumonia model caused by Escherichia coli with or without the GyrA mutation Ser83Leu

Resistance surveillance studies: a multifaceted problem—the fluoroquinolone example

(2012) A. Dalhoff   INFECTION

Impact of low-level fluoroquinolone resistance genes qnrA1, qnrB19 and qnrS1 on ciprofloxacin treatment of isogenic Escherichia coli strains in a murine urinary tract infection model

(2012) L. Jakobsen et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Discrepancies in fluoroquinolone clinical categories between the European Committee on Antimicrobial Susceptibility Testing (EUCAST) and CLSI for Escherichia coli harbouring qnr genes and mutations in gyrA and parC

(2011) J. M. Rodriguez-Martinez et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

In VitroEffect ofqnrA1,qnrB1, andqnrS1Genes on Fluoroquinolone Activity against IsogenicEscherichia coliIsolates with Mutations ingyrAandparC

(2010) A. Briales et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

New Plasmid-Mediated Quinolone Resistance Gene, qnrC, Found in a Clinical Isolate of Proteus mirabilis

(2009) M. Wang et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Impact of Low-Level Resistance to Fluoroquinolones Due to qnrA1 and qnrS1 Genes or a gyrA Mutation on Ciprofloxacin Bactericidal Activity in a Murine Model of Escherichia coli Urinary Tract Infection

(2009) N. Allou et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Plasmid-Mediated Quinolone Resistance: a Multifaceted Threat

(2009) J. Strahilevitz et al.   CLINICAL MICROBIOLOGY REVIEWS

qnrD, a Novel Gene Conferring Transferable Quinolone Resistance in Salmonella enterica Serovar Kentucky and Bovismorbificans Strains of Human Origin

(2008) L. M. Cavaco et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Efficacy of amoxycillin–clavulanate in an experimental model of murine pneumonia caused by AmpC-non-hyperproducing clinical isolates of Escherichia coli resistant to cefoxitin

(2008) F. Docobo-Pérez et al.   CLINICAL MICROBIOLOGY AND INFECTION

Activity of ciprofloxacin and levofloxacin in experimental pneumonia caused by Klebsiella pneumoniae deficient in porins, expressing active efflux and producing QnrA1

(2008) J.M. Rodríguez-Martínez et al.   CLINICAL MICROBIOLOGY AND INFECTION